Real-world impact of infliximab precision-guided dosing on management of patients with IBD
The American Journal of Managed Care · 01.10.2023 · 29 (Suppl 12) · S227-S235
DOI: 10.37765/ajmc.2023.89447 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Managed Care, online erschienen am 12.10.2023. Verfasst von Bincy P Abraham und 5 weiteren Autor:innen. Beteiligte Einrichtung: Prometheus Laboratories Inc, 9410 Carroll Park Dr, San Diego, CA 92121. Email: ashim@prometheuslabs.com. Hauptthemen laut MEDLINE: Gastrointestinal Agents, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Prometheus Laboratories Inc, 9410 Carroll Park Dr, San Diego, CA 92121. Email: ashim@prometheuslabs.com.
Zitieren
APA
Abraham, B. P., Ziring, D. A., Dervieux, T., Han, P. A., Shim, A., & Battat, R. (2023). Real-world impact of infliximab precision-guided dosing on management of patients with IBD. The American Journal of Managed Care, 29(Suppl 12), S227-S235. https://doi.org/10.37765/ajmc.2023.89447
Vancouver
Abraham BP, Ziring DA, Dervieux T, Han PA, Shim A, Battat R. Real-world impact of infliximab precision-guided dosing on management of patients with IBD. The American Journal of Managed Care. 2023;29(Suppl 12):S227-S235. doi:10.37765/ajmc.2023.89447
BibTeX
@article{Abraham2023,
author = {Abraham, Bincy P and Ziring, David A and Dervieux, Thierry and Han, Patricia Aragon and Shim, Andrew and Battat, Robert},
title = {Real-world impact of infliximab precision-guided dosing on management of patients with IBD},
journal = {The American Journal of Managed Care},
year = {2023},
volume = {29},
number = {Suppl 12},
pages = {S227--S235},
doi = {10.37765/ajmc.2023.89447}
}
EUVIMED